ArticlePeerJ2024
Reversal of cholestatic liver disease by the inhibition of sphingosine 1-phosphate receptor 2 signaling.
Huiling Cao et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
8 papers cite it
this paperpooled itcites it